JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120224

Rapamycin, mTORC1 complex inhibitor

Be the first to review this product! Submit a review

|

(27 Publications)

MW 914.2 Da, Purity >98%. Immunosuppressant and antifungal agent. Complexes with FKBP-12 and inhibits mTOR (mammalian target of rapamycin). In complex with its cellular receptor, the FK506-binding protein (FKBP12), rapamycin binds and inhibits the function of the mammalian target of rapamycin (mTOR).
2 Images
Functional Studies - Rapamycin, mTORC1 complex inhibitor (AB120224)
  • FuncS

Unknown

Functional Studies - Rapamycin, mTORC1 complex inhibitor (AB120224)

MCF7 cells were incubated at 37°C for 1h with vehicle control (0 μM) and different concentrations of rapamycin (ab120224). Decreased expression of mTOR (phospho S2448) (ab51044) in MCF7 cells correlates with an increase in rapamycin concentration, as described in literature.

Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 30 μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 5% BSA before being incubated with ab51044 at 1 μg/ml and ab8227 at 1 μg/ml overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP (ab97051) at 1/10000 dilution and visualised using ECL development solution.

Chemical Structure - Rapamycin, mTORC1 complex inhibitor (AB120224)
  • Chemical Structure

Lab

Chemical Structure - Rapamycin, mTORC1 complex inhibitor (AB120224)

2D chemical structure image of ab120224, Rapamycin, mTORC1 complex inhibitor

Key facts

CAS number

53123-88-9

Purity

>98%

Form

Solid

form

Molecular weight

914.2 Da

Molecular formula

C<sub>5</sub><sub>1</sub>H<sub>7</sub><sub>9</sub>NO<sub>1</sub><sub>3</sub>

PubChem

9854380

Nature

Synthetic

Solubility

Soluble in DMSO to 50 mM

Biochemical name

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone

Biological description

Immunosuppressant and antifungal agent . Complexes with FKBP-12 and inhibits mTOR (mammalian target of rapamycin). In complex with its cellular receptor, the FK506-binding protein (FKBP12), rapamycin binds and inhibits the function of the mammalian target of rapamycin (mTOR).

Canonical smiles

CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC

Isomeric smiles

C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC

InChi

InChI=1S/C51H79NO13/c1-30-16-12-11-13-17-31(2)42(61-8)28-38-21-19-36(7)51(60,65-38)48(57)49(58)52-23-15-14-18-39(52)50(59)64-43(33(4)26-37-20-22-40(53)44(27-37)62-9)29-41(54)32(3)25-35(6)46(56)47(63-10)45(55)34(5)24-30/h11-13,16-17,25,30,32-34,36-40,42-44,46-47,53,56,60H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12+,31-17+,35-25+/t30-,32-,33-,34-,36-,37-,38+,39+,40-,42+,43+,44-,46-,47+,51-/m1/s1

InChiKey

QFJCIRLUMZQUOT-LBFZIKHJSA-N

IUPAC Name

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (27)

Recent publications for all applications. Explore the full list and refine your search

International journal of molecular sciences 26: PubMed40429945

2025

Preconditioning with Rapamycin Improves Therapeutic Potential of Placenta-Derived Mesenchymal Stem Cells in Mouse Model of Hematopoietic Acute Radiation Syndrome.

Applications

Unspecified application

Species

Unspecified reactive species

Vasilii Slautin,Vladislav Ivanov,Alexandr Bugakov,Anna Chernysheva,Ilya Gavrilov,Irina Maklakova,Vladimir Bazarnyi,Dmitry Grebnev,Olga Kovtun

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2402671 PubMed39206719

2024

FOXO1-NCOA4 Axis Contributes to Cisplatin-Induced Cochlea Spiral Ganglion Neuron Ferroptosis via Ferritinophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Xue Wang,Lei Xu,Yu Meng,Fang Chen,Jinzhu Zhuang,Man Wang,Weibin An,Yuechen Han,Bo Chu,Renjie Chai,Wenwen Liu,Haibo Wang

Heliyon 10:e31799 PubMed38882290

2024

Role of plasmacytoid dendritic cells in vascular dysfunction in mice with renovascular hypertension.

Applications

Unspecified application

Species

Unspecified reactive species

Balaji Srinivas,Kiran Alluri,Nour-Eddine Rhaleb,Souad Belmadani,Khalid Matrougui

EMBO reports 25:1075-1105 PubMed38396206

2024

TORC1 is an essential regulator of nutrient-controlled proliferation and differentiation in Leishmania.

Applications

Unspecified application

Species

Unspecified reactive species

Elmarie Myburgh,Vincent Geoghegan,Eliza Vc Alves-Ferreira,Y Romina Nievas,Jaspreet S Grewal,Elaine Brown,Karen McLuskey,Jeremy C Mottram

The Journal of pathology 262:441-453 PubMed38186269

2024

TRPM2-dependent autophagy inhibition exacerbates oxidative stress-induced CXCL16 secretion by keratinocytes in vitiligo.

Applications

Unspecified application

Species

Unspecified reactive species

Pan Kang,Yinghan Wang,Jianru Chen,Yuqian Chang,Weigang Zhang,Tingting Cui,Xiuli Yi,Shuli Li,Chunying Li

Lipids in health and disease 22:156 PubMed37736721

2023

Sirt6 enhances macrophage lipophagy and improves lipid metabolism disorder by regulating the Wnt1/β-catenin pathway in atherosclerosis.

Applications

Unspecified application

Species

Unspecified reactive species

Tingting Wang,Zheng Cheng,Ran Zhao,Jin Cheng,He Ren,Pengke Zhang,Pengyun Liu,Qimeng Hao,Qian Zhang,Xiaolei Yu,Dongdong Sun,Dongwei Zhang

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37:e23011 PubMed37249374

2023

Autophagy inhibition mediated by intrauterine miR-1912-3p/CTSD programming participated in the susceptibility to osteoarthritis induced by prenatal dexamethasone exposure in male adult offspring rats.

Applications

Unspecified application

Species

Unspecified reactive species

Huasong Shi,Bin Li,Dingmei Zhang,Hui Han,Hangyuan He,Jiayong Zhu,Hui Wang,Liaobin Chen

The FEBS journal 290:1596-1624 PubMed36239430

2022

Early loss of endogenous NAD following rotenone treatment leads to mitochondrial dysfunction and Sarm1 induction that is ameliorated by PARP inhibition.

Applications

Unspecified application

Species

Unspecified reactive species

Ankita Sarkar,Sourav Dutta,Malinki Sur,Semanti Chakraborty,Puja Dey,Piyali Mukherjee

Infection and immunity 90:e0001622 PubMed35587202

2022

Coxiella burnetii Plasmid Effector B Promotes LC3-II Accumulation and Contributes To Bacterial Virulence in a SCID Mouse Model.

Applications

Unspecified application

Species

Unspecified reactive species

Mengjiao Fu,Jianing Zhang,Mingliang Zhao,Shan Zhang,Lupeng Dai,Xuan Ouyang,Yonghui Yu,Bohai Wen,Dongsheng Zhou,Yansong Sun,Jun Jiao,Xiaolu Xiong

Frontiers in immunology 12:739039 PubMed35185859

2022

Characterization of Interplay Between Autophagy and Ferroptosis and Their Synergistical Roles on Manipulating Immunological Tumor Microenvironment in Squamous Cell Carcinomas.

Applications

Unspecified application

Species

Unspecified reactive species

Lijie Chen,Xing Niu,Xue Qiao,Sai Liu,Hongmei Ma,Xueqing Shi,Xuemei He,Ming Zhong
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com